BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• CSL Behring Awards Emerging Coagulation Specialists Across The Globe To Support Advancements In The Care Of Patients With Bleeding Disorders

  July 25, 2016

   · 

  3 min read
• Bio NC

  PPD Earns Recognition For Multimedia And Digital Communications

  July 25, 2016

   · 

  4 min read
• BioForest

  Just Biotherapeutics Secures $14 Million Series A2 Funding To Build Laboratory, Pilot Plant And GMP Capabilities

  July 25, 2016

   · 

  2 min read
• BIOPHYTIS Receives Belgian Regulatory Authorization To Start Sarconeos Pharmacokinetics Study In Elderly Healthy Volunteers (SARA-PK)

  July 25, 2016

   · 

  2 min read
• Bio NC

  T3D Therapeutics Chosen As Late-Breaking Addition To Alzheimer’s Association International Conference To Discuss Rapid Onset Of Cognitive Improvement With T3D-959

  July 25, 2016

   · 

  7 min read
• Prokarium Receives £2 Million In Government Contracts To Develop New Vaccines Against Emerging Diseases And Bioterrorist Threats

  July 25, 2016

   · 

  3 min read
• Drug Development

  PTC Therapeutics Provides Regulatory Update On Translarna (Ataluren)

  July 25, 2016

   · 

  11 min read
• Pharm Country

  Prairie Dog Tech, LLC, Adds New ATP/Surveillance Module To THE OBSERVER Mobile App To Help Hospital Staff Embrace Proactive Measures In Cleaning, Maintenance Of Endoscopic Devices

  July 25, 2016

   · 

  3 min read
• Business

  DJO Global Announces Date For Release Of Second Quarter 2016 Results

  July 25, 2016

   · 

  1 min read
• Drug Development

  Alnylam Announces New Positive Interim Phase I Study Results For Fitusiran, A Once-Monthly, Subcutaneous, Investigational Rnai Therapeutic Targeting Antithrombin For The Treatment Of Hemophilia And Rare Bleeding Disorders

  July 25, 2016

   · 

  20 min read